Abbott Laboratories (SWX:ABT)
Switzerland flag Switzerland · Delayed Price · Currency is CHF
93.50
0.00 (0.00%)
Sep 30, 2024, 9:05 AM CET

Abbott Laboratories Revenue

Abbott Laboratories had revenue of $10.36B USD in the quarter ending March 31, 2025, with 3.95% growth. This brings the company's revenue in the last twelve months to $42.34B, up 5.00% year-over-year. In the year 2024, Abbott Laboratories had annual revenue of $41.95B with 4.59% growth.

Revenue (ttm)
$42.34B
Revenue Growth
+5.00%
P/S Ratio
4.97
Revenue / Employee
$371.44K
Employees
114,000
Market Cap
185.85B CHF

Revenue Chart

* This company reports financials in USD.

History

Fiscal Year End Revenue Change Growth
Dec 31, 202441.95B1.84B4.59%
Dec 31, 202340.11B-3.54B-8.12%
Dec 31, 202243.65B578.00M1.34%
Dec 31, 202143.08B8.47B24.47%
Dec 31, 202034.61B2.70B8.48%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Roche Holding AG 62.40B
Novartis AG 46.87B
Lonza Group AG 6.57B
Alcon 8.98B
Galderma Group AG 4.02B
Straumann Holding AG 2.50B
Sonova Holding AG 3.71B
Sandoz Group AG 9.41B
Revenue Rankings